|
2025
|
Invention
|
Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof.
The present d... |
|
2023
|
Invention
|
Monoclonal antibodies to programmed death 1 (pd-1).
The present invention provides isolated mono... |
|
2022
|
Invention
|
Human monoclonal antibodies to fucosyl-gm1 and methods for
using anti-fucosyl-gm1 antibodies.
Th... |
|
|
Invention
|
Human monoclonal antibodies to programmed death ligand 1 (pd-l1).
The present disclosure provide... |
|
|
Invention
|
Cation exchange chromatography methods. The present invention provides improved methods of protei... |
|
2021
|
Invention
|
Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof. The present di... |
|
|
Invention
|
Interferon receptor 1 antibodies and their uses.
The present invention provides isolated human m... |
|
2020
|
Invention
|
Antibodies against clostridium difficile toxins and uses thereof.
Antibodies that specifically b... |
|
2019
|
Invention
|
Human artificial chromosome containing human antibody lambda light chain gene and non-human anima... |
|
|
Invention
|
Interferon receptor 1 antibodies and their uses. The present invention provides isolated human mo... |
|
|
Invention
|
Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies.
Th... |
|
2018
|
Invention
|
Human ctla-4 antibodies and their uses.
The presently subject matter provides novel human sequen... |
|
|
Invention
|
Fully human antibodies to btla.
The present invention relates to binding compounds specific for ... |
|
2017
|
Invention
|
Compositions and methods for treating cocaine-related disorders. Methods for treating a cocaine-r... |
|
|
Invention
|
Interferon alpha antibodies and their uses.
The present invention provides isolated anti-interfe... |
|
|
Invention
|
Hco32 and hco27 and related examples. The instant invention relates to transgenic non-human anima... |
|
2016
|
Invention
|
Human antibodies that bind cd22 and uses thereof.
The present disclosure provides isolated monoc... |
|
|
Invention
|
Monoclonal antibodies to programmed death 1 (pd-1). The present invention provides isolated monoc... |
|
|
Invention
|
Transgenic transchromosomal rodents for making human antibodies. The present invention provides n... |
|
|
Invention
|
Human monoclonal antibodies to programmed death ligand 1 (pd-l1). The present disclosure provides... |
|
|
Invention
|
Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors.
This invention provi... |
|
|
Invention
|
Fully human antibodies to btla. The present invention relates to binding compounds specific for B... |
|
|
Invention
|
Human monoclonal antibodies to o8e. The present disclosure provides isolated monoclonal antibodie... |
|
2015
|
Invention
|
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof. 5 are as def... |
|
|
Invention
|
Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies. The... |
|
|
Invention
|
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof.
The pr... |
